NCT03348280

Brief Summary

This trial will evaluate whether a particular type of circulating white blood cell, monocytes, from type 2 diabetics with high blood pressure and vitamin D deficiency vs. sufficiency will induce hormones that increase blood pressure.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
8mo left

Started Sep 2017

Longer than P75 for all trials

Geographic Reach
1 country

2 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress93%
Sep 2017Dec 2026

Study Start

First participant enrolled

September 1, 2017

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

October 23, 2017

Completed
28 days until next milestone

First Posted

Study publicly available on registry

November 20, 2017

Completed
9.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

December 24, 2025

Status Verified

December 1, 2025

Enrollment Period

9.3 years

First QC Date

October 23, 2017

Last Update Submit

December 17, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Renin production by monocytes

    Blood will be collected for isolation of monocytes. These cells will then be cultured to determine whether there is monocyte stimulation of a hormone that induces high blood pressure (renin) in kidney cells.

    2 weeks

Secondary Outcomes (1)

  • Renin production by monocyte media

    2 weeks

Study Arms (2)

Vitamin D Deficient

Type 2 diabetics with high blood pressure and 25-hydroxyvitamin D levels of \<20 ng/ml

Diagnostic Test: Blood draw

Vitamin D Sufficient

Type 2 diabetics with high blood pressure and 25-hydroxyvitamin D levels of \>30 ng/ml

Diagnostic Test: Blood draw

Interventions

Blood drawDIAGNOSTIC_TEST

Blood will be drawn to isolate monocytes after 2 weeks off of blood pressure lowering medications.

Vitamin D DeficientVitamin D Sufficient

Eligibility Criteria

Age25 Years - 80 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

T2DM patients with hypertension

You may qualify if:

  • Type 2 diabetes (T2DM)
  • Age: 25-80 years old
  • Vitamin 25(OH)D3 levels \<20 or \>30 ng/ml.
  • HbA1c: 5.5%-9.5%
  • Blood Pressure: \<160/100 mm Hg on BP lowering medications and
  • Blood Pressure: \>120/80 to 160/100 mmHg without BP lowering medications

You may not qualify if:

  • Recent weight loss of more than 5% within 3 months prior to screening
  • Current Pregnancy
  • Hypercalcemia
  • Previous heart attack and stroke
  • Heart failure
  • Atrial fibrillation
  • Heavy alcohol consumption
  • Extreme diets (Atkins, South Beach)
  • Chronic renal failure: stage 4 or worse
  • \>2 + proteinuria on urine sample
  • Chronic diseases known to affect immunity

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Barnes-Jewish & Washington University Diabetes Center

St Louis, Missouri, 63110, United States

Location

Washington University

St Louis, Missouri, 63110, United States

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 2HypertensionVitamin D Deficiency

Interventions

Blood Specimen Collection

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesVascular DiseasesCardiovascular DiseasesAvitaminosisDeficiency DiseasesMalnutritionNutrition Disorders

Intervention Hierarchy (Ancestors)

Specimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, OperativeInvestigative Techniques

Study Officials

  • Carlos Bernal-Mizrachi, MD

    Washington University School of Medicine

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 23, 2017

First Posted

November 20, 2017

Study Start

September 1, 2017

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

December 24, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations